Analysts have been eager to weigh in on the Healthcare sector with new ratings on Thermo Fisher (TMO), Eli Lilly & Co (LLY) and Adocia (ADOCY).
Thermo Fisher (TMO)
In a report released today, Derik De Bruin from Merrill Lynch maintained a Buy rating on Thermo Fisher, with a price target of $550.00. The company’s shares closed last Friday at $512.30, close to its 52-week high of $532.57.
According to TipRanks.com, Bruin is a 4-star analyst with an average return of 9.6% and a 63.1% success rate. Bruin covers the Healthcare sector, focusing on stocks such as Exact Sciences, Personalis, and Seer.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Thermo Fisher with a $534.08 average price target, a 4.3% upside from current levels. In a report issued on January 8, Credit Suisse also upgraded the stock to Buy with a $556.00 price target.
See today’s analyst top recommended stocks >>
Eli Lilly & Co (LLY)
Mizuho Securities analyst Vamil Divan maintained a Hold rating on Eli Lilly & Co today and set a price target of $164.00. The company’s shares closed last Friday at $166.41, close to its 52-week high of $173.90.
According to TipRanks.com, Divan is a 1-star analyst with an average return of -0.5% and a 48.0% success rate. Divan covers the Healthcare sector, focusing on stocks such as Biohaven Pharmaceutical Holding Co, Satsuma Pharmaceuticals, and ACADIA Pharmaceuticals.
Currently, the analyst consensus on Eli Lilly & Co is a Moderate Buy with an average price target of $181.91.
Adocia (ADOCY)
H.C. Wainwright analyst Douglas Tsao maintained a Buy rating on Adocia today and set a price target of $19.00. The company’s shares closed last Wednesday at $10.65.
According to TipRanks.com, Tsao is a 4-star analyst with an average return of 12.6% and a 52.5% success rate. Tsao covers the Healthcare sector, focusing on stocks such as Biohaven Pharmaceutical Holding Co, Crinetics Pharmaceuticals, and Protagonist Therapeutics.
Currently, the analyst consensus on Adocia is a Moderate Buy with an average price target of $19.00.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
